We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current EDIT market cap is 435.25M. The company's latest EPS is USD -1.8728 and P/E is -2.84.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42k | 6.54M | 9.85M | 2.89M | 5.34M |
| Operating Income | -57.52M | -63.45M | -50.96M | -44.1M | -50.16M |
| Net Income | -55.73M | -60.74M | -49.04M | -40.29M | -45.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 20.53M | 90.73M | 25.54M | 19.71M | 78.12M |
| Operating Income | -140.92M | -134.84M | -193.15M | -225.95M | -169.18M |
| Net Income | -133.75M | -115.98M | -192.5M | -220.43M | -153.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 531.03M | 514.32M | 464.11M | 541.95M | 504.65M |
| Total Liabilities | 116.28M | 153.64M | 146.63M | 142.04M | 144.19M |
| Total Equity | 414.75M | 360.68M | 317.47M | 399.92M | 360.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 508.89M | 572.6M | 677.48M | 514.32M | 499.15M |
| Total Liabilities | 246.45M | 179.02M | 123.84M | 153.64M | 150.06M |
| Total Equity | 262.44M | 393.59M | 553.64M | 360.68M | 349.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -135.08M | -177.35M | -35.77M | -74.48M | -109.94M |
| Investing | 141.6M | 114.07M | 23.27M | 36.25M | -66.57M |
| Financing | 665k | 1.28M | N/A | 117.53M | 117.53M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -40.67M | -179.84M | -163.8M | -177.35M | -132.18M |
| Investing | 12.25M | -140.52M | -54.47M | 114.07M | -3.73M |
| Financing | 131.82M | 224.12M | 282.11M | 1.28M | 118.04M |
| Market Cap | 435.25M |
| Price to Earnings Ratio | -2.84 |
| Price to Sales Ratio | 5.57 |
| Price to Cash Ratio | 3.52 |
| Price to Book Ratio | 1.25 |
| Dividend Yield | - |
| Shares Outstanding | 81.81M |
| Average Volume (1 week) | 1.81M |
| Average Volume (1 Month) | 1.7M |
| 52 Week Change | -31.62% |
| 52 Week High | 11.91 |
| 52 Week Low | 5.11 |
| Spread (Intraday) | 0.13 (2.37%) |
| Company Name | Editas Medicine Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.editasmedicine.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
